Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥19.2bn2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥32.4bn2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥13.7bn2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥3.3bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥3.6bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥3.2bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥6.9bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.6bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥2.2bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥4.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.7bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥2.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥2.7bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥136.1bnat 2024-09-30Cons.Assets IFRS
Total assets¥122.5bnat 2024-03-31Cons.Assets IFRS
Total assets¥100.0bnat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥63.7bnat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥51.8bnat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥72.4bnat 2024-09-30Cons.Equity IFRS
Net assets / equity¥70.7bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥68.7bnat 2023-09-30Cons.Equity IFRS
Net assets / equity¥64.5bnat 2023-03-31dCons.Equity IFRS
Equity (owners)¥72.1bnat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥70.6bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥68.6bnat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥27.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥14.5bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥21.5bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥22.8bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥10.8bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥17m2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥2.0bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥4.5bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥24.9bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥3.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥6.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥16.6bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥341m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥33.512024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥71.762023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥42.22023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥33.182024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥69.952023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥40.532023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio52.9%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio57.6%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio68.6%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 35
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥21m
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥21m
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥379m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2024-04-01 → 2024-09-30¥649m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2024-04-01 → 2024-09-30¥649m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2024-04-01 → 2024-09-30¥116m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue2024-04-01 → 2024-09-30¥15.5bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue external2024-04-01 → 2024-09-30¥15.5bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥21m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentsegment profit2024-04-01 → 2024-09-30¥3.8bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue2024-04-01 → 2024-09-30¥3.1bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue external2024-04-01 → 2024-09-30¥3.1bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentsegment profit2024-04-01 → 2024-09-30¥1.1bn
—segment totalrevenue2024-04-01 → 2024-09-30¥19.2bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥19.2bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥21m
—segment totalsegment profit2024-04-01 → 2024-09-30¥5.0bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥338m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue2023-04-01 → 2023-09-30¥1.3bn
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.2bn
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥50m
jpcrp040300-q2r_E35308-000Dispensing Pharmacy Supportreportable segmentsegment profit2023-04-01 → 2023-09-30¥133m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue2023-04-01 → 2023-09-30¥9.8bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue external2023-04-01 → 2023-09-30¥9.8bn
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥38m
jpcrp040300-q2r_E35308-000Healthcare Big Datareportable segmentsegment profit2023-04-01 → 2023-09-30¥2.5bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentrevenue external2023-04-01 → 2023-09-30¥2.7bn
jpcrp040300-q2r_E35308-000Tele Medicinereportable segmentsegment profit2023-04-01 → 2023-09-30¥1.0bn
—segment totalrevenue2023-04-01 → 2023-09-30¥13.8bn
—segment totalrevenue external2023-04-01 → 2023-09-30¥13.7bn
—segment totalrevenue intersegment2023-04-01 → 2023-09-30¥89m
—segment totalsegment profit2023-04-01 → 2023-09-30¥3.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 769
ItemContextValueUnit
Business results of group (text)FilingDateInstantText · Plus
Description of business (text)FilingDateInstantText · Plus
Business risks (text)FilingDateInstantText · Plus
Management analysis of financial position operating results and cash flows (text)FilingDateInstantText · Plus
Critical contracts for operation (text)FilingDateInstantText · Plus
Total number of shares (text)FilingDateInstantText · Plus
Issued shares total number of shares etc (text)FilingDateInstantText · Plus
Class issued shares total number of shares etcFilingDateInstant_OrdinaryShareMember
Original text (Japanese)普通株式
Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registeredFilingDateInstant_OrdinaryShareMember
Original text (Japanese)東京証券取引所(プライム市場)
Description issued shares total number of shares etcFilingDateInstant_OrdinaryShareMemberText · Plus
Details of employee share option program (text)FilingDateInstantText · Plus
Other information on share acquisition rights (text)FilingDateInstantText · Plus
Exercises etc of moving strike convertible bonds etc (text)FilingDateInstantText · Plus
Changes in number of issued shares stated capital etc (text)FilingDateInstantText · Plus
Major shareholders (text)FilingDateInstantText · Plus
Name major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)オムロン株式会社
Address major shareholdersCurrentQuarterInstant_No1MajorShareholdersMember
Original text (Japanese)京都府京都市下京区塩小路通堀川東入南不動堂町801番地
Name major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)日本マスタートラスト信託銀行株式会社(信託口)
Address major shareholdersCurrentQuarterInstant_No2MajorShareholdersMember
Original text (Japanese)東京都港区赤坂一丁目8番1号
Name major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)ノーリツ鋼機株式会社
Address major shareholdersCurrentQuarterInstant_No3MajorShareholdersMember
Original text (Japanese)東京都港区麻布十番一丁目10番10号
Name major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)株式会社日本カストディ銀行(信託口)
Address major shareholdersCurrentQuarterInstant_No4MajorShareholdersMember
Original text (Japanese)東京都中央区晴海一丁目8番12号
Name major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)松島 陽介
Address major shareholdersCurrentQuarterInstant_No5MajorShareholdersMember
Original text (Japanese)東京都港区
Name major shareholdersCurrentQuarterInstant_No6MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No6MajorShareholdersMember
Original text (Japanese) 56,GRAND RUE L-1660 LUXEMBOURG (東京都千代田区丸の内一丁目4番5号 決済事業部)
Name major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)山元 雄太
Address major shareholdersCurrentQuarterInstant_No7MajorShareholdersMember
Original text (Japanese)東京都港区
Name major shareholdersCurrentQuarterInstant_No8MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No8MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No9MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No9MajorShareholdersMemberText · Plus
Name major shareholdersCurrentQuarterInstant_No10MajorShareholdersMemberText · Plus
Address major shareholdersCurrentQuarterInstant_No10MajorShareholdersMemberText · Plus
Issued shares voting rights (text)FilingDateInstantText · Plus
Description issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsTreasurySharesEtcMember-
Description issued shares voting rightsCurrentQuarterInstant_SharesWithFullVotingRightsOtherMember
Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。
Description issued shares voting rightsCurrentQuarterInstant_SharesLessThanOneUnitMember-
Treasury shares etc (text)FilingDateInstantText · Plus
Name of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)株式会社JMDC
Address of shareholder treasury shares etcCurrentQuarterInstant_Row1Member
Original text (Japanese)東京都港区芝大門二丁目5番5号
Information about officers (text)FilingDateInstantText · Plus
Description of fact that consolidated financial statements have been prepared in accordance with IFRS financial informationCurrentYTDDurationText · Plus
Type1 semi annual consolidated financial statements financial informationCurrentYTDDurationText · Plus
Note on independent audit financial informationCurrentYTDDurationText · Plus
Condensed quarterly consolidated statement of financial position IFRS (text)CurrentYTDDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass rounding
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass